Sameer Satija, MD
Clinical Cardiac Electrophysiology · Margate, FLNPI 1235317876
Payments from drug & device makers
Across 1,386 payments — averaging $47.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$24K
- Medtronic$19K
- Pfizer$7K
- Boston Scientific$4K
- E.r. Squibb & Sons, L.L.C.$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$3K
- plus $6K from 23 others
What the payments were for
- Consulting fees$1,8443%
- Speaking & faculty fees$11,32517%
- Travel & lodging$4,0506%
- Food & beverage$48,50974%
- Education$490%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 561 | $24,119 |
| Medtronic(2 entities) | 468 | $18,713 |
| Pfizer | 31 | $7,188 |
| Boston Scientific | 120 | $3,647 |
| E.r. Squibb & Sons, L.L.C. | 14 | $3,381 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 25 | $2,907 |
| Atricure, Inc. | 20 | $1,407 |
| Biosense Webster, Inc. | 40 | $1,067 |
| Johnson & Johnson(2 entities) | 41 | $762 |
| Cordis US CORP. | 5 | $642 |
| Cardiva Medical, Inc. | 18 | $402 |
| Impulse Dynamics (USA) Inc. | 4 | $324 |
| Cvrx, Inc. | 8 | $294 |
| Sanofi-aventis U.S. LLC | 8 | $255 |
| Angiodynamics, Inc. | 1 | $167 |
| Edwards Lifesciences | 1 | $154 |
| Biotronik Inc. | 2 | $139 |
| Novartis | 1 | $118 |
| Acutus Medical, Inc. | 3 | $90 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $66 |
| Medicomp Inc | 2 | $58 |
| Boehringer Ingelheim | 3 | $57 |
| Medline Industries LP | 2 | $36 |
| Lexicon Pharmaceuticals, Inc. | 1 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
| Akcea Therapeutics, Inc. | 1 | $21 |
| Terumo Medical Corporation | 1 | $20 |
| Bardy Diagnostics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$9,813
- COBALT DR MRI SURESCAN$4,078
- Confirm Rx$3,396
- AVEIR$2,588
- LifeVest$2,250
- TYRX$1,973
- Accent Pacemaker$1,199
- Assurity Pacemaker$1,196
- Fortify Assura, Ellipse ICD$1,104
- Micra$993
- WATCHMAN Access System$932
- AZURE XT DR MRI SURESCAN$700
- MYNX CONTROL$563
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$555
- ENSITE$549
- WATCHMAN FLX$502
- AMPLATZER Occluders$500
- Allure Quadra RF CRT Pacemaker$471
- OPTIMIZER$461
- LINQ II$456
How this compares
$66,126 in reported general payments places this provider in the 65th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 210 | $183,844 |
| XareltoRivaroxaban | 122 | $111,040 |
| Flecainide Acetate | 85 | $2,940 |
| Metoprolol Succinate | 146 | $1,531 |
| SotalolSotalol Hcl | 121 | $1,517 |
| Midodrine Hcl | 12 | $1,358 |
| Sotalol AfSotalol Hcl | 56 | $685 |
| ClopidogrelClopidogrel Bisulfate | 35 | $491 |
| Amiodarone Hcl | 56 | $445 |
| Metoprolol Tartrate | 67 | $269 |
| Carvedilol | 15 | $150 |
| Atenolol | 27 | $141 |
| Losartan Potassium | 12 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $7,188 | $183,844210 claims |
| Johnson & JohnsonXarelto | $762 | $111,040122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Margate
- Jose Osorio FilhoMiami$16.4M
- Saumil OzaJacksonville$4.1M
- Usman SiddiquiWinter Park$3.6M
- David KenigsbergFort Lauderdale$1.3M
- Venkata SagiJacksonville$1.2M
- Raul WeissMiami Beach$1.1M
- Robert FishelAtlantis$1.1M
- Naushad ShaikKissimmee$1.1M
- Neal KaveshLakeland$967K
- Antonio MorettaSarasota$891K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.